These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6118437)

  • 41. Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
    Escher EH; Guillemette G
    J Med Chem; 1979 Sep; 22(9):1047-50. PubMed ID: 226704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
    Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
    Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury.
    Larrivée JF; Bachvarov DR; Houle F; Landry J; Huot J; Marceau F
    J Immunol; 1998 Feb; 160(3):1419-26. PubMed ID: 9570562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.
    Rhaleb NE; Télémaque S; Rouissi N; Dion S; Jukic D; Drapeau G; Regoli D
    Hypertension; 1991 Jan; 17(1):107-15. PubMed ID: 1846119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin.
    Deblois D; Bouthillier J; Marceau F
    Br J Pharmacol; 1988 Apr; 93(4):969-77. PubMed ID: 3390663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Action and metabolism of des(Arg)kinins in mesenteric arteries.
    Churchill L; McGiff JC; Ward PE
    Adv Exp Med Biol; 1986; 198 Pt A():571-5. PubMed ID: 3812095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.
    Drummond GR; Cocks TM
    Br J Pharmacol; 1995 Nov; 116(5):2473-81. PubMed ID: 8581287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological activities of kinins modified at the N- or at the C-terminal end.
    Drouin JN; Gaudreau P; St-Pierre S; Regoli D
    Can J Physiol Pharmacol; 1979 Sep; 57(9):1018-23. PubMed ID: 519533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of bradykinin receptor mediating relaxation of cat cerebral arteries in vivo and in vitro.
    Whalley ET; Wahl M
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(1):66-71. PubMed ID: 6136000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological profiles of the human and rabbit B1 receptors.
    Gobeil F; Neugebauer W; Nguyen-Le XK; Nea Allogho S; Pheng LH; Blouin D; Whalley ET; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):591-5. PubMed ID: 9276134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
    MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
    Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of kinins on isolated blood vessels. Role of endothelium.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Caranikas S
    Can J Physiol Pharmacol; 1982 Dec; 60(12):1580-3. PubMed ID: 7165854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinins, receptors, antagonists.
    Regoli D
    Adv Exp Med Biol; 1986; 198 Pt A():549-58. PubMed ID: 2880480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the agents affecting cyclic nucleotide metabolism on the bradykinin- and des-Arg9-bradykinin-induced relaxations and contractions in isolated rat duodenum.
    Oztürk Y
    Gen Pharmacol; 1994 Nov; 25(7):1389-95. PubMed ID: 7896050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
    Field JL; Butt SK; Morton IK; Hall JM
    Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
    Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
    Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels.
    Regoli D; Drapeau G; Rovero P; Dion S; Rhaleb NE; Barabé J; D'Orléans-Juste P; Ward P
    Eur J Pharmacol; 1986 Aug; 127(3):219-24. PubMed ID: 2875891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.